학술논문

Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 15 January 2022, 28(2):298-307)
Subject
Language
English
ISSN
15573265
10780432